http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112190561-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-424
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-424
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
filingDate 2020-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-112190561-B
titleOfInvention Preparation method of amoxicillin and clavulanate potassium tablets
abstract The invention discloses a preparation method of an amoxicillin and clavulanate potassium tablet, which comprises the following steps: mixing and drying amoxicillin heavy powder, microcrystalline cellulose and colloidal silicon dioxide until the water activity of the mixed powder is less than 0.05aW to obtain mixed powder I; adding a mixed raw material of potassium clavulanate and microcrystalline cellulose, carboxymethyl starch sodium, colloidal silicon dioxide and microcrystalline cellulose into the mixed powder I, and mixing to obtain mixed powder II; adding magnesium stearate into the mixed powder II, and mixing to obtain mixed powder II; directly tabletting the mixed powder III to obtain amoxicillin and clavulanate potassium tablets; taking the compressed amoxicillin potassium clavulanate tablets as tablet core coatings to obtain finished amoxicillin potassium clavulanate tablets; wherein the mass ratio of amoxicillin to clavulanic acid is 7:1, and the coating solvent is a mixed solution of isopropanol and dichloromethane. The invention obtains the amoxicillin and clavulanate potassium tablet product with good stability and dissolution rate by improving the combination relationship of the components and the preparation process.
priorityDate 2020-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535338
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33613
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462222
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6435924
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280980
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507912
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559508
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449454525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397383
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452080028

Total number of triples: 44.